Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.

Zinzani, Pier Luigi

Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients. [electronic resource] - American journal of hematology Nov 2013 - E273-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-8652

10.1002/ajh.23540 doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Female
Follow-Up Studies
Humans
Lymphoma, Follicular--diagnosis
Male
Middle Aged
Mitoxantrone--administration & dosage
Neoplasm Grading
Neoplasm Staging
Prognosis
Recurrence
Retrospective Studies
Rituximab
Survival Analysis
Vidarabine--administration & dosage